NCT06243510View on ClinicalTrials.gov

Comparison of Apixaban Versus Enoxaparin

NAEnrolling by invitationINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

November 24, 2023

Primary Completion Date

December 1, 2025

Study Completion Date

March 1, 2026

Conditions
Bladder Cancer
Interventions
OTHER

apixaban

Participants will be randomized to receive a prescription for prophylactic apixaban

OTHER

enoxaparin

Participants will be randomized to receive a prescription for prophylactic enoxaparin

Trial Locations (1)

19104

Hospital of the University of Pennsylvania, Philadelphia

All Listed Sponsors
collaborator

American Urological Association

OTHER

lead

Abramson Cancer Center at Penn Medicine

OTHER